HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort

Elyse C. Page, Susan L. Heatley, Laura N Eadie, Barbara J. McClure, Charles E. de Bock, Sofia A. Omari, David T Yeung, Timothy P. Hughes, Paul Q. Thomas, Deborah L. White